Andrew Baum

Andrew Baum, M.D., is a former surgeon and globally respected strategist who brings deep clinical, scientific, and financial expertise to advising Pfizer’s CEO on enterprise‑level strategy, innovation, and long‑term value creation. With more than 30 years of experience across the biopharmaceutical sector and financial services industry, Dr. Baum is known for his ability to translate complex science and market dynamics into clear strategic insight.

Prior to assuming his role as Senior Strategic Advisor to the CEO in April 2026, Dr. Baum served as Pfizer’s Chief Strategy and Innovation Officer, where he helped shape the company’s strategic direction, innovation agenda, and portfolio priorities. He also served as Chair of the company’s Portfolio Management Team. Before joining Pfizer, Dr. Baum was Global Head of Healthcare Research at Citi Research, a role he held from 2011, following a 14‑year tenure covering European Pharmaceuticals at Morgan Stanley. Earlier in his career, he worked as a U.K. Pharmaceuticals and Biotechnology analyst at Salomon Brothers.

Dr. Baum began his professional career in medicine and was a practicing physician at the John Radcliffe Hospital, having completed his medical training at the University of Oxford. This clinical foundation continues to inform his perspective on patient impact, scientific rigor, and the healthcare ecosystem.

He has been recognized six times as the top‑ranked European Pharmaceutical Analyst in the Developed Europe & Emerging EMEA Research Survey, with his teams consistently placing among the top three in major external investor polls, including Institutional Investor, Greenwich, and Reuters. Dr. Baum is frequently sought after by senior leaders across the healthcare industry for his insights and has lectured at organizations such as IO360, the British Institute of Comparative Law, and the World Vaccine Congress, in addition to guest presentations for leading management consultancies.

Dr. Baum holds a Master of Arts degree in Physiological Sciences and a Bachelor of Medicine, Bachelor of Surgery (BM ChB) degree from Oxford University and is a Fellow of the Royal Society of Medicine.